Favorable Outcomes of Pediatric Hematopoietic Cell Transplant Patients Receiving Regen-COV2 for Prophylaxis Against Severe COVID-19 Disease

Detalles Bibliográficos
Autores principales: Graham, Rudi-Ann Tamara, Qayed, Muna, Leung, Kathryn S, Haight, Ann E, Parikh, Suhag, Watkins, Ben K., Horwitz, Edwin, Chandrakasan, Shanmuganathan, Schoettler, Michelle Long, Bernardo, Valeria, Harris, Anora, Landry, Kelly, Yee, Marianne, Williams, Kirsten M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. 2022
Materias:
Poster Session - Infectious Diseases and Cytotoxic T Lymphocytes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930022/
http://dx.doi.org/10.1016/S2666-6367(22)00643-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930022/
http://dx.doi.org/10.1016/S2666-6367(22)00643-1

Ejemplares similares